Use of fluoroquinolones and the risk of aortic and mitral regurgitation: A nationwide case-crossover study.

The findings suggested that patients treated with FQs could be warned about the potential risk for MR even after considering the possibility of protopathic bias. Reducing unnecessary FQs prescriptions may be considered to reduce the risk of valvular heart disease.